|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61P 1/00 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| C07K 16/28 | (2006.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61K 9/19 | (2006.01) | ||
| A61K 47/26 | (2006.01) | ||
| A61K 47/18 | (2017.01) |
| (11) | Number of the document | 3329965 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18150968.8 |
| Date of filing the European patent application | 2012-05-02 | |
| (97) | Date of publication of the European application | 2018-06-06 |
| (45) | Date of publication and mention of the grant of the patent | 2025-03-19 |
| (46) | Date of publication of the claims translation | 2025-06-10 |
| (30) | Number | Date | Country code |
| 201161481533 P | 2011-05-02 | US | |
| 201161550545 P | 2011-10-24 | US | |
| 201261585859 P | 2012-01-12 | US |
| (72) |
DILUZIO, Willow , US
TRUONG, Nobel T. , US
VARGA, Csanad M. , US
PALANIAPPAN, Vaithianathan , US
BROWN, Jason , US
FOX, Irving H. , US
SCHOLZ, Catherine , US
|
| (73) |
Millennium Pharmaceuticals, Inc. ,
40 Landsdowne Street, Cambridge, MA 02139,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Anti-alfa4beta7-antikūno dozavimo režimas |
| DOSING REGIMEN OF ANTI-ALPHA4BETA7-ANTIBODY |
| Payment date | Validity (years) | Amount | |
| 2025-04-23 | 14 | 289.00 EUR |
| 2026-05-02 |